Serevent diskus 50 MCG 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FWHZ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,281
Award facts
- Contract value 100% obligated
- $5,280.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,280.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Serevent Diskus 50 mcg (60-count units) with an ultimate completion date of January 29, 2026. This non-set-aside, competitively awarded contract reflects a routine pharmaceutical procurement supporting federal medical supply needs. The award is a child delivery order under AmerisourceBergen's parent company Cencora, Inc., which holds a significant $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) running through December 2026. This comprehensive IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company demonstrates extensive capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains through its competitive federal contract awards. This delivery order for Serevent Diskus—a long-acting beta-agonist inhaled medication used in respiratory disease management—exemplifies the company's role in supplying essential medications to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the DLA's flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FWHZ9?
SPE2DR26FWHZ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FWHZ9 worth?
The government has obligated $5,281 on SPE2DR26FWHZ9.
Is contract SPE2DR26FWHZ9 an order under another contract?
Yes. SPE2DR26FWHZ9 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWHZ9 competed?
The extent of competition for SPE2DR26FWHZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award